VOYA Investment Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
Other funds holding JNCE
VOYA Investment Management's JNCE Position: Q2 2023 in Review
VOYA Investment Management sold out of Jounce Therapeutics, Inc. Common Stock (JNCE) in Q2 2023, closing a stake of 18,274 shares — an estimated $33.8K sold.
VOYA Investment Management first reported a position in JNCE in Q1 2021 and held it in 9 quarters. The position peaked at $266K in Q4 2021. 1 fund tracked by Wall St. Rank holds JNCE as of Q2 2023.
- VOYA Investment Management reported no remaining Jounce Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
- VOYA Investment Management sold 18,274 Jounce Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $33.8K.
- VOYA Investment Management first reported a position in Jounce Therapeutics, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
- VOYA Investment Management's Jounce Therapeutics, Inc. Common Stock position peaked at $266K in Q4 2021.
- 1 fund tracked by Wall St. Rank held Jounce Therapeutics, Inc. Common Stock as of Q2 2023.
Based on VOYA Investment Management's 13F filing for Q2 2023, filed 14 Aug 2023.